As filed with the Securities and Exchange Commission on September 2, 2008
Registration No. 333-122455
- -----------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________
FORM S-8
POST-EFFECTIVE AMENDMENT NO. 1 TO
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
_____________
DIALYSIS CORPORATION OF AMERICA
(Exact name of registrant as specified in its charter)
Florida 59-1757642
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)
1302 Concourse Drive, Suite 204
Linthicum, Maryland 21090
(Address of Principal Executive Offices)
1999 STOCK INCENTIVE PLAN OF DIALYSIS CORPORATION OF AMERICA
(Full title of the plan)
_____________
Stephen W. Everett Copy to:
President and Chief Executive Officer
Dialysis Corporation of America Lawrence E. Jaffe, Esq.
1302 Concourse Drive, Suite 204 Jaffe & Falk, LLC
Linthicum, Maryland 21090 2337 West 76th Street
(Name and address for agent of service) Hialeah, Florida 33016
(410) 694-0500
(Telephone number, including area code, for agent of service)
Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of "large accelerated filer," "accelerated
filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
(Check one)
Large accelerated filer [ ] Accelerated filer [ ]
Non-accelerated filer [ ] Smaller reporting company [ ]
- -----------------------------------------------------------------------------
TERMINATION OF REGISTRATION
On February 1, 2005, Dialysis Corporation of America ("DCA") filed a
registration statement on Form S-8 (Registration No. 333-122455) with the
Securities and Exchange Commission to register 62,000 shares of its common
stock, $.01 par value (the "Common Stock") for issuance upon exercise of
options for such shares held by nine key employees. All the options have
been exercised and the registration statement has been completed.
Based on the foregoing, pursuant to this post-effective amendment no. 1,
DCA terminates the Form S-8 registration statement (Registration No. 333-
122455) as of this date.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this post-effective
amendment no. 1 to the registration statement to be signed on its behalf by
the undersigned, thereunto duly authorized, in the City of Linthicum, State
of Maryland, on September 2, 2008.
DIALYSIS CORPORATION OF AMERICA
/s/ Stephen W. Everett
By:__________________________________
Stephen W. Everett
President and Chief Executive
Officer
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities and on the date indicated.
Signatures Title Date
- ---------- ----- ----
Chairman of the Board
/s/ Thomas K. Langbein of Directors September 2, 2008
- ------------------------
Thomas K. Langbein
President and Chief Executive
/s/ Stephen W. Everett Officer and Director (Principal) September 2, 2008
- ------------------------ Executive Officer)
Stephen W. Everett
Vice President, Finance and Chief
/s/ Andrew J. Jeanneret Financial Officer (Principal September 2, 2008
- ------------------------ Financial Officer
Andrew J. Jeanneret
* Vice President and Chief Accounting
- ------------------------ Officer (Principal Accounting Officer)
Daniel R. Ouzts
* Director
- ------------------------
Robert W. Trause
* Director
- ------------------------
Alexander Bienenstock
* Director
- ------------------------
Peter D. Fischbein
* Thomas K. Langbein, the undersigned attorney-in-fact, by signing his name
hereto, does hereby sign and execute this post-effective amendment no. 1 to
the registration statement on behalf of the above officer and directors
pursuant to the powers of attorney filed with the Securities and Exchange
Commission.
/s/ Thomas K. Langbein
September 2, 2008 By: -------------------------------
Thomas K. Langbein,
Attorney-in-Fact